Literature DB >> 29982716

Limitations of the 2015 ATA Guidelines for Prediction of Thyroid Cancer: A Review of 1947 Consecutive Aspirations.

Amit Pandya1, Elaine M Caoili1, Farah Jawad-Makki1, Ashish P Wasnik1, Prasad R Shankar1, Ron Bude1, Megan R Haymart2, Matthew S Davenport1.   

Abstract

Background: The 2015 American Thyroid Association (ATA) guidelines have been proposed to aid in the management of thyroid nodules by determining whether fine needle aspiration is indicated. Objective: To determine whether the ATA guidelines contribute to the overdiagnosis of thyroid cancer. Patients and
Methods: This was a retrospective cohort study of ultrasound-imaged thyroid nodules (n = 1947) consecutively aspirated at a tertiary care center from 1 October 2009 to 22 February 2016. Nodules were retrospectively reviewed, assigned a 2015 ATA morphology, and placed into one of five 2015 ATA categories of risk (ATA-1, <1% risk of malignancy; ATA-2, <3% risk; ATA-3, 5% to 10% risk, ATA-4: 10% to 20% risk; ATA-5, >70% to 90% risk) by a reader who was blinded to cytology. ATA category was compared with cytopathology. The positive predictive value (PPV) of each ATA category was calculated with respect to cancer. Numbers needed to aspirate and Pearson correlations were calculated. Interrater agreement for ATA category across five readers was assessed.
Results: The PPV for cancer increased by ATA category [category 1 to 5, respectively: 0% (0/14), 2% (4/249), 5% (36/733), 12% (104/850), 28% (28/101)]. The number needed to sample to detect one papillary cancer was 125 (ATA-2), 49 (ATA-3), 13 (ATA-4), and 5 (ATA-5). The overall interrater agreement for ATA score across all five readers was fair (intraclass correlation coefficient 0.460). Conclusions: The 2015 ATA guidelines stratify risk for thyroid cancer; however, the stratification system is overly optimistic regarding cancer detection rates for the higher-risk nodules, and there is only fair interrater agreement.

Entities:  

Mesh:

Year:  2018        PMID: 29982716     DOI: 10.1210/jc.2018-00792

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

1.  A Specific Predicting Model for Screening Skip Metastasis From Patients With Negative Central Lymph Nodes Metastasis in Papillary Thyroid Cancer.

Authors:  Zheyu Yang; Yu Heng; Qiwu Zhao; Zichao Cao; Lei Tao; Weihua Qiu; Wei Cai
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-30       Impact factor: 5.555

2.  The Added Value of Operator's Judgement in Thyroid Nodule Ultrasound Classification Arising From Histologically Based Comparison of Different Risk Stratification Systems.

Authors:  Bruno Madeo; Giulia Brigante; Anna Ansaloni; Erica Taliani; Shaniko Kaleci; Maria Laura Monzani; Manuela Simoni; Vincenzo Rochira
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-07       Impact factor: 5.555

3.  Is Male Sex A Prognostic Factor in Papillary Thyroid Cancer?

Authors:  Aleksandra Gajowiec; Anna Chromik; Kinga Furga; Alicja Skuza; Danuta Gąsior-Perczak; Agnieszka Walczyk; Iwona Pałyga; Tomasz Trybek; Estera Mikina; Monika Szymonek; Klaudia Gadawska-Juszczyk; Artur Kuchareczko; Agnieszka Suligowska; Jarosław Jaskulski; Paweł Orłowski; Magdalena Chrapek; Stanisław Góźdź; Aldona Kowalska
Journal:  J Clin Med       Date:  2021-05-31       Impact factor: 4.241

4.  Is patient age associated with risk of malignancy in a ≥4 cm cytologically benign thyroid nodule?

Authors:  Whitney Sutton; Joseph K Canner; Lisa M Rooper; Jason D Prescott; Martha A Zeiger; Aarti Mathur
Journal:  Am J Surg       Date:  2020-06-02       Impact factor: 2.565

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.